JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer

  • 0CPI - Carolina Urologic Research Center, Myrtle Beach, SC 29572, USA.
Future Oncology +

|

November 18, 2024

|

November 18, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Testosterone recovery after prostate cancer treatment is crucial. Delayed recovery can negatively impact patient health and quality of life, as explored in recent studies on androgen deprivation therapy.

Area Of Science

  • Oncology
  • Endocrinology
  • Urology

Background

  • Androgen deprivation therapy (ADT) aims to suppress testosterone in advanced prostate cancer.
  • Prolonged low testosterone (hypogonadism) negatively affects patient health and quality of life.
  • Understanding testosterone recovery is vital for optimizing ADT outcomes.

Purpose Of The Study

  • To examine the impact of delayed testosterone recovery on clinical outcomes in prostate cancer patients.
  • To assess testosterone recovery rates with different gonadotropin-releasing hormone (GnRH) therapies.

Main Methods

  • A real-world study evaluated delayed testosterone recovery and clinical outcomes.
  • A subgroup analysis of the HERO trial compared GnRH agonist (leuprolide) and antagonist (relugolix) therapies.
  • Testosterone levels were monitored to assess recovery patterns.

Main Results

  • Delayed testosterone recovery was linked to adverse clinical outcomes in prostate cancer patients.
  • Different GnRH therapies demonstrated varying rates and speeds of testosterone recovery.
  • Further details on specific outcomes and recovery rates are discussed.

Conclusions

  • Testosterone recovery is a significant factor in managing advanced prostate cancer patients on ADT.
  • The choice of GnRH therapy may influence the rate of testosterone recovery.
  • Optimizing ADT protocols to support timely testosterone recovery is warranted.

Keywords:

Related Concept Videos

Disorders of the Male Reproductive System 01:20

337

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Testosterone: Functions and Regulation 01:26

560

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

Menopause 01:28

140

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...